HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

R Hare Selected Research

everninomicin

3/2001In vitro uptake of SCH 27899 (evernimicin) by rat alveolar macrophages.
1/2001Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


R Hare Research Topics

Disease

6Infection
01/2006 - 03/2000
3Heart Failure
08/2004 - 06/2002
2Body Weight (Weight, Body)
01/2001 - 03/2000
1Zygomycosis (Phycomycosis)
01/2006
1Exanthema (Rash)
01/2006
1Pulmonary Aspergillosis
03/2001
1Legionnaires' Disease (Legionnaire's Disease)
12/2000

Drug/Important Bio-Agent (IBA)

2posaconazoleFDA Link
01/2006 - 03/2000
2DiureticsIBA
08/2004 - 06/2002
2everninomicinIBA
03/2001 - 01/2001
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2002
1Brain Natriuretic Peptide (Natrecor)FDA Link
06/2002
1pro-brain natriuretic peptide (1-76)IBA
06/2002
1Proteins (Proteins, Gene)IBA
08/2001
1Interleukin-12 (IL 12)IBA
08/2001
1CytokinesIBA
08/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2001
1chloroflurenol-methyl (CF 1)IBA
03/2001
1Carrier Proteins (Binding Protein)IBA
01/2001
1Interleukin-18 (Interleukin 18)IBA
12/2000
1Interferon-gamma (Interferon, gamma)IBA
12/2000

Therapy/Procedure

1Salvage Therapy
01/2006